Clofoctol as a novel senolytic drug eliminating therapy-induced senescent glioma cells
Neuro-Oncology Advances · 12.01.2026 · 8 (1)
DOI: 10.1093/noajnl/vdag102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 13.04.2026. Verfasst von Yuxin Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Scie…. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Background
Glioblastoma is the most common malignant brain glioma, accounting for ∼48% of malignant central nervous system tumors. Targeting glioma stem cells and senescent glioma cells represents promising therapeutic strategies. In our previous study, we identified the clofoctol as a candidate drug targeting glioma stem cells with good blood-brain barrier permeability and potent anti-glioblastoma efficacy. Comprehensively demonstrating the impact of clofoctol on glioblastoma might provide novel strategies for the treatment of glioblastoma.
Methods
By utilizing single-cell RNA sequencing of tumor tissue, we demonstrated the suppression effect of clofoctol on senescent glioma cell. Cellular RNA sequencing, molecular docking and CETSA were used to further confirm target of clofoctol. Ultimately, GL261 and orthotopic patient-derived xenograft animal models was performed to assess whether the senolytic effect of clofoctol could enhance TMZ therapy.
Results
Clofoctol treatment reduced the senescence level (SASPs, senescence-related genes, and the proportion of senescent cells) in GL261-derived tumor single-cell RNA sequencing. In vitro, clofoctol could target senescent glioma cells and induce cell death through apoptosis and ferroptosis. P53 was identified as the functional protein which elicited the effect of clofoctol. In vivo, clofoctol exhibited senolytic activity and synergized with TMZ, leading to extended survival in glioblastoma mouse model.
Conclusions
Our study demonstrated the clinical drug clofoctol could target chemotherapy-induced senescent glioma cells through P53 and trigger cell apoptotic and ferroptotic death. We further confirmed a synergistic effect between clofoctol and temozolomide which could be a novel therapeutic approach for glioblastoma therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences &…
- Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
ORCID-Profile: Xiaozhong Peng
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- State Key Laboratory Special Fund
Zitieren
APA
Zhang, Y., Wang, Z., Wang, Y., Li, E., Wu, F., Hou, L., Yin, B., Qiang, B., Han, W., & Peng, X. (2026). Clofoctol as a novel senolytic drug eliminating therapy-induced senescent glioma cells. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag102
Vancouver
Zhang Y, Wang Z, Wang Y, Li E, Wu F, Hou L, et al. Clofoctol as a novel senolytic drug eliminating therapy-induced senescent glioma cells. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag102
BibTeX
@article{Zhang2026,
author = {Zhang, Yuxin and Wang, Zhixing and Wang, Yue and Li, Enyan and Wu, Fan and Hou, Lin and Yin, Bin and Qiang, Boqin and Han, Wei and Peng, Xiaozhong},
title = {Clofoctol as a novel senolytic drug eliminating therapy-induced senescent glioma cells},
journal = {Neuro-Oncology Advances},
year = {2026},
volume = {8},
number = {1},
doi = {10.1093/noajnl/vdag102}
}
EUVIMED